MBIO

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 0———— — Gross profit 0———— — Operating expenses 1.02 M253 K885 K624 K670 K 2.43 M Selling/general/admin expenses -223 K1.22 M787 K957 K987 K 3.95 M Research & development -664 K———— — Operating income -1.02 M-253 K-885 K-624 K-670 K -2.43 M Non-Operating Income, Total 65 K100 K123 K156 K132 K 511 K Interest expense, net of interest capitalized 1 000———— — Non-Operating Income, excl. Interest Expenses 65 K100 K123 K156 K132 K 511 K Unusual income/expense -1 000———— — Pretax income -953 K-153 K-762 K-468 K-538 K -1.92 M Equity in earnings ————— — Taxes ————-265 K — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -952 K-153 K-762 K-468 K-538 K -1.92 M Discontinued operations ————— — Net income -952 K-153 K-762 K-468 K-538 K -1.92 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -952 K-153 K-762 K-468 K-538 K -1.92 M Basic earnings per share (Basic EPS) 6.56-0.05-0.19-0.07-0.08 -0.39 Diluted earnings per share (Diluted EPS) 6.56-0.05-0.19-0.07-0.08 -0.39 Average basic shares outstanding 609.7 K2.86 M4.02 M6.24 M4.91 M 18.03 M Diluted shares outstanding 609.7 K2.86 M4.02 M6.24 M4.91 M 18.03 M EBITDA -966 K———— — EBIT -1.02 M———— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 51 K34 K000 34 K